Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Cardiovascular Interventions 2002: XIIIth International Course on Interventional Cardiology, Frankfurt/Main, Germany

Cardiovascular Interventions 2002: XIIIth International Course on Interventional Cardiology,... From the Red Cross Hospital Cardiology Center, FranyUrthUain, Germany As in previous years, the December issue of the Journal of Interventional Cardiology is dedicated to “CardiovascularInterventions,” the annual meeting on interventional cardiology in FrankfuWain, Germany. Within a 2-day comprehensive symposium, “Cardiovascular Interventions 2002” will provide an update on the most challenging topics in interventional cardiology. The most up-to-date clinical research will be summarized and there will be a presentation of the transfer of clinical research into practice by interactive live demonstrations. Progress in cardiovascular gene therapy will be highlighted by reports on initial clinical experiences with stem cell therapy for the treatment of myocardial infarctions and the use of vascular growth factors for coronary and peripheral angiogenesis. The clinical role of the “unstable coronary lesion” will be analyzed focusing on the basics of pathology and involving clinical assessments using intravascular ultrasound, elastography, and thermography. Stent-based delivery of antiproliverative drugs will be reviewed discussing the individual mechanism of Address for reprints: Jiirgen Haase, M.D., Ph.D., Red Cross Hospital Cardiology Center, Pfingstweidstrasse 11, 60316 Frankfurt/ M i ,Germany. Fax: +49-69-493276; e-mail: kardio.centrum@ an t-online.de action and its potential value for controlling intimal hyperplasia following percutaneous coronary interventions: rapamycin acting by inhibition of the cell cycle in late G1-phase, paclitaxel by suppression microtubule function, batimastat by inhibition of smooth muscle cell migration, corticosteroids by inhibition of multiple immune mediators, and antisense technology by inhibition of the cell cycle at multiple points. This novel approach towards restenosis prevention will be opposed to a critical reappraisal of brachytherapy as the single remaining measure of treating intimal hyperplasia, focusing on the most challenging lesion subsets especially prone to in-stent restenosis such as ostial lesions, bifurcation lesions, lesions in small vessels, and saphenous vein grafts. Finally, protection of microvascular perfusion during percutaneous interventions will be reviewed with regard to stent implantation in saphenous vein grafts, renal artery stenting, stenting of carotid arteries, and the special issue of stenting in acute myocardial infarctions. Last but not least, prevention and management of complications during and after percutaneous cardiovascular interventions will be discussed with a special view on vascular perforations and the prevention of stent thrombosis following brachytherapy and implantation of drug-eluting stents. Vol. 15, No. 6,2002 Journal of Interventional Cardiology http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Interventional Cardiology Wiley

Cardiovascular Interventions 2002: XIIIth International Course on Interventional Cardiology, Frankfurt/Main, Germany

Loading next page...
 
/lp/wiley/cardiovascular-interventions-2002-xiiith-international-course-on-7czHj0auyq

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wiley
Copyright
Copyright © 2002 Wiley Subscription Services, Inc., A Wiley Company
ISSN
0896-4327
eISSN
1540-8183
DOI
10.1111/j.1540-8183.2002.tb01086.x
Publisher site
See Article on Publisher Site

Abstract

From the Red Cross Hospital Cardiology Center, FranyUrthUain, Germany As in previous years, the December issue of the Journal of Interventional Cardiology is dedicated to “CardiovascularInterventions,” the annual meeting on interventional cardiology in FrankfuWain, Germany. Within a 2-day comprehensive symposium, “Cardiovascular Interventions 2002” will provide an update on the most challenging topics in interventional cardiology. The most up-to-date clinical research will be summarized and there will be a presentation of the transfer of clinical research into practice by interactive live demonstrations. Progress in cardiovascular gene therapy will be highlighted by reports on initial clinical experiences with stem cell therapy for the treatment of myocardial infarctions and the use of vascular growth factors for coronary and peripheral angiogenesis. The clinical role of the “unstable coronary lesion” will be analyzed focusing on the basics of pathology and involving clinical assessments using intravascular ultrasound, elastography, and thermography. Stent-based delivery of antiproliverative drugs will be reviewed discussing the individual mechanism of Address for reprints: Jiirgen Haase, M.D., Ph.D., Red Cross Hospital Cardiology Center, Pfingstweidstrasse 11, 60316 Frankfurt/ M i ,Germany. Fax: +49-69-493276; e-mail: kardio.centrum@ an t-online.de action and its potential value for controlling intimal hyperplasia following percutaneous coronary interventions: rapamycin acting by inhibition of the cell cycle in late G1-phase, paclitaxel by suppression microtubule function, batimastat by inhibition of smooth muscle cell migration, corticosteroids by inhibition of multiple immune mediators, and antisense technology by inhibition of the cell cycle at multiple points. This novel approach towards restenosis prevention will be opposed to a critical reappraisal of brachytherapy as the single remaining measure of treating intimal hyperplasia, focusing on the most challenging lesion subsets especially prone to in-stent restenosis such as ostial lesions, bifurcation lesions, lesions in small vessels, and saphenous vein grafts. Finally, protection of microvascular perfusion during percutaneous interventions will be reviewed with regard to stent implantation in saphenous vein grafts, renal artery stenting, stenting of carotid arteries, and the special issue of stenting in acute myocardial infarctions. Last but not least, prevention and management of complications during and after percutaneous cardiovascular interventions will be discussed with a special view on vascular perforations and the prevention of stent thrombosis following brachytherapy and implantation of drug-eluting stents. Vol. 15, No. 6,2002 Journal of Interventional Cardiology

Journal

Journal of Interventional CardiologyWiley

Published: Dec 1, 2002

There are no references for this article.